Alzheimer's Disease Biomarkers and Physiopathology

Dear Colleagues,

"Alzheimer's Disease Biomarkers and Physiopathology" is a Special Issue that examines the pathological mechanisms and characteristics of Alzheimer's disease. It provides an in-depth analysis of the latest research on the disease, with a focus on the biomarkers defining the diagnosis, prognosis, and treatment monitoring of Alzheimer’s disease, as well as the role of concomitant cerebrovascular disease. The Special Issue also includes articles discussing potential therapeutic targets and the latest diagnostic techniques for Alzheimer's disease. It is designed to assist researchers and clinicians in better understanding and managing this neurodegenerative disorder.

Dr. Silvia Ingala
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• Alzheimer's disease
• biomarkers
• physiopathology
• diagnosis
• prognosis
• treatment monitoring
• concomitant cerebrovascular disease
• neurodegenerative disorder